Determination of quinapril and quinaprilat in human plasma by ultraperformance liquid chromatography-electrospray ionization mass spectrometry

Biomedical Chromatography

Volumn 23, Issue 5, 2009, Pages 492-498

  Dasandi, Bhavesh ^a,b   Shah, Sanjay ^a   Shivprakash, ^b  

^a Pilvai Science College   (India)

^b Synchron Research Services Private Limited   (India)

Author keywords

Acquity; Human plasma; LC MS MS; Quinapril; UPLC

Indexed keywords

LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMA (HUMAN);

ACQUITY; HUMAN PLASMAS; LC-MS-MS; LC.MS/MS; LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-MASS SPECTROMETRIES; LISINOPRIL; QUINAPRIL; ULTRAPERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRIES; UPLC; UPLC-MS/MS;

ELECTROSPRAY IONIZATION;

LISINOPRIL; QUINAPRIL; QUINAPRILAT; TETRAHYDROISOQUINOLINE DERIVATIVE;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG ISOLATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; ELUTION; HUMAN; LIQUID CHROMATOGRAPHY; PRODUCT RECOVERY; QUADRUPOLE MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS; BLOOD; ECONOMICS; METHODOLOGY; STANDARD; TIME; VALIDATION STUDY;

CHROMATOGRAPHY, LIQUID; HUMANS; LISINOPRIL; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TETRAHYDROISOQUINOLINES; TIME FACTORS;

EID: 67649641754     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1143     Document Type: Article

References (10)

1. Abbara Ch, Aymard G, Hinh S and Diquet B. Simultaneous determination of quinapril and its active metabolite quinaprilat in human plasma using high-performance liquid chromatography with ultraviolet detection. Journal of Chromatogrphy B 2002; 766: 199-207.
2. Begg EJ, Robson RA, Ikram H, Richards AM, Bammert-Adams JA, Olson SC, Posvar EL, Rece PA and Sedman AJ. The pharmacokinetics of quinapril and quinaprilat in patients with congestive heart failure. British Journal of Clinical Pharmacology 1994; 37: 302-304.
3. Blum RA, Olson SC, Kohli RK, Horvath AM, Sedman AJ and Posvar EL. Pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients on chronic hemodialysis. Journal of Clinical Pharmacology 1990; 30: 938-942.
4. Ferry JJ, Horvath AM, Easton-Taylor M, Toothaker RD and Colburn WA. Determination of quinapril and its active metabolite in human plasma and urine by gas chromatography with electron-capture detection. Journal of Chromatogrphy and Biomedical Applications 1987; 421: 187-191.
5. Jemal H. High throughput quantitative bioanalysis by LC-MS/MS. Biomedical Chromatography 2000; 14: 422.
6. Kugler AR, Olson SC and Smith DE. Determination of quinapril and quinaprilat by high-performance liquid chromatography with radiochemical detection, coupled to liquid scintillation counting spectrometry. Journal of Chromatogrphy B Biomedical Application 1995; 666: 360-367.
7. Prieto JA, Alonso RM, Jimenez RM and Blanco A. Solid-phase extraction and high-performance liquid chromatography applied to the determination of quinapril and its metabolite quinaprilat in urine. Journal of Chromatogrphic Science 2001; 39: 153-159.
8. Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, Layloff T, Viswanathan CT, Cook CE, McDowall RA, Pittman KA and Sidney S. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies Conference report. European Journal of Drug Metabolism and Pharmacokinetics 1991; 16: 249.
9. Squire IB, MacFadyen RJ, Lees KYR, Hillis WS and Reid JL. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure. British Journal of Clinical Pharmacology 1994; 38: 117-123.
10. Yamada S, Murakoa I, Kato H, Hiromi Y, Takasu R, Seno H, Kawahara H and Nabeshima T. Elimination kinetics of quinaprilat and perindoprilat in hypertensive patients with renal failure on haemodialysis. Biological and Pharmaceutical Bulletin 2003; 26: 872-875.